Item 5.07. Submission of Matters to a Vote of Security Holders.

As previously reported, on May 6, 2021, LifeSci Acqisition II Corp. (“LSAQ”), LifeSci Acquisition II Merger Sub, Inc. (“Merger Sub”), and Science 37, Inc. (“Science 37”), entered into a merger agreement (the “Merger Agreement”), pursuant to which Merger Sub will merge with and into Science 37, with Science 37 surviving the merger and becoming a wholly-owned subsidiary of LSAQ (collectively with the other transactions contemplated under the Merger Agreement, the “Business Combination”). The combined company after the Business Combination is referred to in this Current Report on Form 8-K as the “Combined Company.”

LSAQ held its special meeting of stockholders on October 4, 2021 (the “Special Meeting”). On August 27, 2021, the record date for the Special Meeting, there were 10,011,301 shares of LSAQ’s common stock entitled to vote at the Special Meeting. At the Special Meeting, there were 7,100,516 shares voted by proxy or in person, which is 70.93% of the total outstanding shares.

The final results for each of the matters submitted to a vote of LSAQ’s stockholders at the Special Meeting are as follows:

Proposal 1. Business Combination Proposal

Proposal 1, to approve the Business Combination, was passed with voting results as follows:

Proposal 2. Charter Approval Proposal

Proposal 2, to approve the Second Amended and Restated Certificate of Incorporation of LSAQ (the “Amended Charter”), was passed with voting results as follows:

Proposal 3. Governance Proposals

Proposal 3, to approve, on a non-binding advisory basis, five separate governance proposals relating to the following material differences between the first amended and restated certificate of incorporation of LSAQ and the Amended Charter, was passed. The voting results for each of the sub-proposals were as follows:

(a) to increase the number of shares of (i) common stock LSAQ is authorized to issue from 30,000,000 shares to 400,000,000 shares and (ii) preferred stock LSAQ is authorized to issue from 1,000,000 shares to 100,000,000 shares:

(b) require the vote of at least two-thirds (66 and 2/3%) of the voting power of the then outstanding shares of voting stock of LSAQ entitled to vote at an election of directors, rather than a simple majority, to amend, alter, repeal or rescind the certificate of incorporation:

(c) require the vote of at least two-thirds (66 and 2/3%) of the voting power of the then outstanding shares of voting stock of LSAQ entitled to vote at an election of directors, rather than a simple majority, to amend, alter, repeal or rescind the bylaws:

(d) require the vote of at least two-thirds (66 and 2/3%) of the voting power of the outstanding shares of capital stock, rather than a simple majority, to remove a director from office:

(e) remove certain provisions related to LSAQ’s status as a special purpose acquisition company that will no longer be relevant following the closing of the Business Combination:

Proposal 4. Incentive Award Plan

Proposal 4, to approve the Science 37 Holdings, Inc. 2021 Incentive Award Plan, was passed with voting results as follows:

Proposal 5. ESPP Proposal

Proposal 5, to approve the Science 37 Holdings, Inc. 2021 Employee Stock Purchase Plan, was passed with voting results as follows:

Proposal 6. Nasdaq Proposal

Proposal 6, to approve (i) for purposes of complying with Nasdaq Listing Rule 5635 (a) and (b), the issuance of more than 20% of the issued and outstanding shares of common stock and the resulting change in control in connection with the Business Combination, and (ii) for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the common stock in connection with the PIPE investment and the conversion of private placement warrants to shares of common stock upon the consummation of the Business Combination, was passed with voting results as follows: